TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial.

Nourhan El Ahmar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.